Jun 6, 2008
Drug Discovery
RNAi specialist, Japanese drugmaker team up for Asian market in a deal worth up to $1 billion Rick Mullin U.S.-based Alnylam Pharmaceuticals and Japan's Takeda Pharmaceutical have formed an alliance to develop ...
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
